The Latest Cardiac and Vascular News
Company continued to launch new products, win share, and deliver strong earnings growth; market procedure volumes impacted by COVID-19 resurgence DUBLIN, Nov. 23, 2021 /PRNewswire(opens new window)/ — Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2022, which ended October 29, 2021. Key Highlights Revenue of $7.8 billion increased […]
New study shows hypertensive adults can face six times higher heart attack risk after a bout with the seasonal flu LAKE FOREST, Ill., Nov. 23, 2021 /PRNewswire/ — As cold and flu season intensifies across the U.S., global heart health leader OMRON Healthcare, Inc., is issuing a national health alert to the increased […]
MINNEAPOLIS, Nov. 23, 2021 /PRNewswire/ — VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that the company has raised a convertible note financing in addition to a transition in leadership. VentureMed […]
The TORUS 2 study is a prospective, single-arm trial of 188 patients to evaluate safety and effectiveness of the TORUS Stent Graft System in the treatment of PAD in the SFA and proximal popliteal arteries IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held global medical device company dedicated to improving patients’ […]
New data shows improved deep learning algorithm performs equally across all age groups, enabling more patients to benefit from the company’s cardiac diagnostics AI platform PARIS and BOSTON, Nov. 22, 2021 /PRNewswire/ — Cardiologs announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to use its AI-powered cardiac diagnostics platform […]
MEMPHIS, Tenn., Nov. 22, 2021 /PRNewswire/ — Tony and Karyn Tanner of Bossier City, La., knew that this day was coming sooner rather than later for their 17-year-old daughter Madi. Born with tetralogy of Fallot (TOF), a congenital heart defect that changes the flow of blood through the heart, she needed a pulmonary valve replacement, […]
ST. LOUIS PARK, Minn., Nov. 22, 2021 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, announced positive 30-day results following the first successful worldwide procedure using multiple chords to a single anchor. The […]
Approved protocol amendment enables enrollment of ATTR-CM patients in the ongoing first-in-human study of NTLA-2001, a systemically delivered CRISPR/Cas9-based therapy CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA) announced today that the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has approved a protocol amendment […]
Global Post-Market Study Will Assess Long-Term Benefit of Peripheral IVL on the Most Challenging Calcified Lesions, Including Patients with Critical Limb Ischemia SANTA CLARA, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular […]
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the successful completion of the acquisition of Acceleron Pharma Inc. (Nasdaq: XLRN). “This is an important and strategic opportunity for our company to continue growing our cardiovascular portfolio and pipeline, that builds on our […]
